Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of adjuvanted FLU New Generation influenza vaccine versus Fluarix in adults aged 65 years and older
2008-000872-25Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in influenza comparing GSK2186877A arm with Fluarix arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jun 2008; status: completed.
02
Drugs
GSK2186877AFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-000872-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000872-25.